Detalles de la búsqueda
1.
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.
Br J Cancer
; 130(11): 1783-1794, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38519705
2.
Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L.
Cancer Sci
; 113(1): 221-228, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704312
3.
Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non-small cell lung cancer patients with impaired renal function: RESTART trial.
BMC Cancer
; 22(1): 964, 2022 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36076179
4.
Erlotinib for Non-Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101).
Oncologist
; 25(12): e1869-e1878, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32654250
5.
Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer: LOGIK0801.
Oncologist
; 25(8): e1146-e1157, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32385918
6.
Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
Int J Clin Oncol
; 19(4): 601-6, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24158772
7.
Five Cases of Cytokine Release Syndrome in Patients Receiving Cytotoxic Chemotherapy Together With Nivolumab Plus Ipilimumab: A Case Report.
J Thorac Oncol
; 19(2): 337-343, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37943237
8.
Osimertinib readministration for central nervous system metastases in non-small cell lung cancer positive for EGFR activating mutations.
Respir Investig
; 62(3): 334-338, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38412569
9.
Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer: A case report and literature review.
Thorac Cancer
; 15(13): 1106-1111, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38528720
10.
Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma.
JTO Clin Res Rep
; 5(1): 100613, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38229769
11.
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study).
Clin Cancer Res
; 30(6): 1104-1110, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38165684
12.
Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 10(3): 315-324, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127362
13.
Sensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR-tyrosine kinase inhibitors.
Cancer Sci
; 104(5): 584-9, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23387505
14.
Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
Jpn J Clin Oncol
; 43(10): 1018-22, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23917962
15.
Acute myeloid leukemia and myelodysplastic syndrome associated with a combination of immune checkpoint inhibitor and platinum-based chemotherapy.
Thorac Cancer
; 14(22): 2225-2228, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37337950
16.
Phase 1 study of DS-1205c combined with gefitinib for EGFR mutation-positive non-small cell lung cancer.
Cancer Med
; 12(6): 7090-7104, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621830
17.
Durvalumab Plus Concurrent Radiotherapy for Treatment of Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Phase 2 Nonrandomized Controlled Trial.
JAMA Oncol
; 9(11): 1505-1513, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676681
18.
Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors.
Lung Cancer
; 181: 107264, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37276707
19.
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer.
Sci Rep
; 13(1): 3698, 2023 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36878936
20.
Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients.
Cancer Med
; 12(13): 14327-14336, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37211905